Di(2-ethylhexyl)phthalate-induced renal oxidative stress in rats and protective effect of selenium

Toxicology Mechanisms and Methods

Volumn 22, Issue 6, 2012, Pages 415-423

  Erkekoglu, Pinar ^a   Giray, Belma Kocer ^a   Kizilgün, Murat ^b   Rachidi, Walid ^c   Hininger Favier, Isabelle ^d   Roussel, Anne Marie ^d   Favier, Alain ^c   Hincal, Filiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Oncology Research and Training Hospital   (Turkey)

^c CEA GRENOBLE   (France)

^d Domaine Universitaire   (France)

Author keywords

antioxidant enzymes; Di(2 ethylhexyl)phthalate (DEHP); kidney; lipid peroxidation; oxidative stress; selenium deficiency (SeD); selenium supplementation (SeS)

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; SELENIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL; THIOREDOXIN REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION;

ANIMALS; ANTIOXIDANTS; DIETHYLHEXYL PHTHALATE; GLUTATHIONE PEROXIDASE; KIDNEY; ORGAN SIZE; OXIDATIVE STRESS; PLASTICIZERS; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 84862259374     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.666652     Document Type: Article

References (76)

1. Akerboom TP, Sies H. 1981. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Meth Enzymol 77:373-382.
2. Arcadi FA, Costa C, Imperatore C, Marchese A, Rapisarda A, Salemi M, Trimarchi GR, Costa G. 1998. Oral toxicity of bis(2-ethylhexyl) phthalate during pregnancy and suckling in the Long-Evans rat. Food Chem Toxicol 36:963-970. (Pubitemid 28526549)
3. Arnér ES, Zhong L, Holmgren A. 1999. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Meth Enzymol 300:226-239.
4. Behne D, Kyriakopoeulos A, Weiss-Nowak C, Kalckloesch M, Westphal C, Gessner H. 1996. Newly found selenium-containing proteins in the tissues of the rat. Biol Trace Elem Res 55:99-110. (Pubitemid 26427758)
5. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, Lucier GW, Jackson RJ, Brock JW. 2000. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 108:979-982.
6. Borch J, Metzdorff SB, Vinggaard AM, Brokken L, Dalgaard M. 2006. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology 223:144-155. (Pubitemid 43728621)
7. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thévenin M, Jaudon MC, Zingraff J, Verger C, Jungers P, Descamps-Latscha B. 1996. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 21:845-853. (Pubitemid 26365280)
8. Chang M, Burgess JR, Scholz RW, Reddy CC. 1990. The induction of specific rat liver glutathione S-transferase subunits under inadequate selenium nutrition causes an increase in prostaglandin F2 alpha formation. J Biol Chem 265:5418-5423.
9. Chou K, Wright RO. 2006. Phthalates in food and medical devices. J Med Toxicol 2:126-135.
10. Cimini AM, Sulli A, Stefanini S, Serafini B, Moreno S, Rossi L, Giorgi M, Ceru MP. 1994. Effects of Di-(2-ethylhexyl)phthalate on peroxisomes of liver, kidney and brain of lactating rats and their pups. Cell Mol Biol (Noisy-le-grand) 40:1063-1076.
11. Combs GF Jr, Combs SB. 1984. The nutritional biochemistry of selenium. Annu Rev Nutr 4:257-280.
12. Crocker JF, Safe SH, Acott P. 1988. Effects of chronic phthalate exposure on the kidney. J Toxicol Environ Health 23:433-444.
13. David RM, Moore MR, Finney DC, Guest D. 2000. Chronic toxicity of di(2-ethylhexyl)phthalate in mice. Toxicol Sci 58:377-385. (Pubitemid 32042435)
14. Dobashi K, Asayama K, Nakane T, Hayashibe H, Kodera K, Uchida N, Nakazawa S. 1999. Effect of peroxisome proliferator on extracellular glutathione peroxidase in rat. Free Radic Res 31:181-190. (Pubitemid 29435879)
15. Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC. 2002. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11:630-639. (Pubitemid 34760821)
16. Duty SM, Ackerman RM, Calafat AM, Hauser R. 2005. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect 113:1530-1535. (Pubitemid 41614907)
17. Dworkin B, Weseley S, Rosenthal WS, Schwartz EM, Weiss L. 1987. Diminished blood selenium levels in renal failure patients on dialysis: correlations with nutritional status. Am J Med Sci 293:6-12. (Pubitemid 17040492)
18. Erkekoglu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F. 2010a. Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic Biol Med 49:559-566.
19. Erkekoglu P, Rachidi W, Yuzugullu OG, Giray B, Favier A, Ozturk M, Hincal F. 2010b. Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol Appl Pharmacol 248:52-62.
20. Erkekoglu P, Rachidi W, Yüzügüllü OG, Giray B, Oztürk M, Favier A, Hincal F. 2011a. Induction of ROS, p53, p21 in DEHP- and MEHP-exposed LNCaP cells-protection by selenium compounds. Food Chem Toxicol 49:1565-1571.
21. Erkekoglu P, Zeybek ND, Giray B, Asan E, Arnaud J, Hincal F. 2011b. Reproductive toxicity of di(2-ethylhexyl) phthalate in selenium-supplemented and selenium-deficient rats. Drug Chem Toxicol 34:379-389.
22. Erkekoglu P, Giray B, Rachidi W, Hininger-Favier I, Roussel AM, Favier A, Hincal F. 2011c. Effects of di(2-ethylhexyl)phthalate on testicular oxidant/antioxidant status in selenium-deficient and selenium-supplemented rats. Environ Toxicol doi: 10.1002/tox.20776.(Ahead of print).
23. Fan J, Traore K, Li W, Amri H, Huang H, Wu C, Chen H, Zirkin B, Papadopoulos V. 2010. Molecular mechanisms mediating the effect of mono-(2-ethylhexyl) phthalate on hormone-stimulated steroidogenesis in MA-10 mouse tumor Leydig cells. Endocrinology 151:3348-3362.
24. Faure P, LafondJL. Favier AE, Cadet J, Kalnyanaraman, B, Fontecave M, Pierre JL (Eds.), 1995. Measurement of plasma sulfhydryl and carbonyl groups as a possible indicator of protein oxidation, In : Analysis of free radicals in biology systems. Basel, Boston, Berlin: Birkhäuser Press, pp. 237-248.
25. Fischer JL, Lancia JK, Mathur A, Smith ML. 2006. Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. Anticancer Res 26:899-904.
26. Flohé L, Günzler WA. 1984. Assays of glutathione peroxidase. Meth Enzymol 105:114-121. (Pubitemid 14165378)
27. Foote JW, Hinks LJ, Lloyd B. 1987. Reduced plasma and white blood cell selenium levels in haemodialysis patients. Clin Chim Acta 164:323-328. (Pubitemid 17084001)
28. Francescato HD, Costa RS, Rodrigues Camargo SM, Zanetti MA, Lavrador MA, Bianchi MD. 2001. Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 43:77-82. (Pubitemid 32577758)
29. Fromme H, Gruber L, Schlummer M, Wolz G, Böhmer S, Angerer J, Mayer R, Liebl B, Bolte G. 2007. Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. Environ Int 33:1012-1020. (Pubitemid 47500104)
30. Fujieda M, Naruse K, Hamauzu T, Miyazaki E, Hayashi Y, Enomoto R, Lee E, Ohta K, Yamaguchi Y, Wakiguchi H, Enza H. 2007. Effect of selenium-deficient diet on tubular epithelium in normal rats. Pediatr Nephrol 22:192-201. (Pubitemid 44964319)
31. Fujishima Y, Ohsawa M, Itai K, Kato K, Tanno K, Turin TC, Onoda T, Endo S, Okayama A, Fujioka T. 2011. Serum selenium levels in hemodialysis patients are significantly lower than those in healthy controls. Blood Purif 32:43-47.
32. Ganther HE. 1999. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20:1657-1666. (Pubitemid 29410542)
33. Gazouli M, Yao ZX, Boujrad N, Corton JC, Culty M, Papadopoulos V. 2002. Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143:2571-2583. (Pubitemid 34701320)
34. Giray B, Kan E, Bali M, Hincal F, Basaran N. 2003. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. Clin Chim Acta 338:91-98. (Pubitemid 37456695)
35. Grande SW, Andrade AJ, Talsness CE, Grote K, Golombiewski A, Sterner-Kock A, Chahoud I. 2007. A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult female offspring rats. Toxicology 229:114-122. (Pubitemid 44889269)
36. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
37. Halden RU. 2010. Plastics and health risks. Annu Rev Public Health 31:179-194.
38. Hanukoglu I. 2006. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev 38: 171-196. (Pubitemid 43739006)
39. Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. 2004. Medications as a source of human exposure to phthalates. Environ Health Perspect 112:751-753. (Pubitemid 38628406)
40. Heudorf U, Mersch-Sundermann V, Angerer J. 2007. Phthalates: toxicology and exposure. Int J Hyg Environ Health 210: 623-634. (Pubitemid 47539285)
41. Howdeshell KL, Rider CV, Wilson VS, Gray LE Jr. 2008. Mechanisms of action of phthalate esters, individually and in combination, to induce abnormal reproductive development in male laboratory rats. Environ Res 108:168-176.
42. Ishikawa I. 1991. Uremic acquired renal cystic disease. Natural history and complications. Nephron 58:257-267.
43. Jablonska E, Gromadzinska J, Reszka E, Wasowicz W, Sobala W, Szeszenia-Dabrowska N, Boffetta P. 2009. Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur J Nutr 48:383-386.
44. Kallistratos G, Evangelou A, Seferiadis K, Vezyraki P, Barboutis K. 1985. Selenium and haemodialysis: serum selenium levels in healthy persons, non-cancer and cancer patients with chronic renal failure. Nephron 41:217-222. (Pubitemid 15246664)
45. Kambia K, Dine T, Azar R, Gressier B, Luyckx M, Brunet C. 2001. Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing. Int J Pharm 229:139-146. (Pubitemid 32972088)
46. Kasahara E, Sato EF, Miyoshi M, Konaka R, Hiramoto K, Sasaki J, Tokuda M, Nakano Y, Inoue M. 2002. Role of oxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate. Biochem J 365:849-856. (Pubitemid 34864469)
47. Kertai E, Hollósi G, Kovács J, Varga V. 2000. Effect of glycerol-induced acute renal failure and di-2-ethylhexyl phthalate on the enzymes involved in biotransformation of xenobiotixs. Acta Physiol Hung 87:253-265. (Pubitemid 32531250)
48. Kocdor H, Cehreli R, Kocdor MA, Sis B, Yilmaz O, Canda T, Demirkan B, Resmi H, Alakavuklar M, Harmancioglu O. 2005. Toxicity induced by the chemical carcinogen 7,12-dimethylbenz[a]anthracene and the protective effects of selenium in Wistar rats. J Toxicol Environ Health Part A 68:693-701. (Pubitemid 40734184)
49. Koniecki D, Wang R, Moody RP, Zhu J. 2011. Phthalates in cosmetic and personal care products: concentrations and possible dermal exposure. Environ Res 111:329-336.
50. Latini G. 2005. Monitoring phthalate exposure in humans. Clin Chim Acta 361:20-29. (Pubitemid 41382607)
51. Lockitch G. 1989. Selenium: clinical significance and analytical concepts. Crit Rev Clin Lab Sci 27:483-541.
52. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. 1994. Oxidative stress in haemodialysis. QJM 87:679-683.
53. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
54. Lyche JL, Gutleb AC, Bergman A, Eriksen GS, Murk AJ, Ropstad E, Saunders M, Skaare JU. 2009. Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev 12:225-249.
55. Maiorino M, Gregolin C, Ursini F. 1990. Phospholipid hydroperoxide glutathione peroxidase. Meth Enzymol 186:448-457. (Pubitemid 20279987)
56. Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474.
57. Messaoudi I, Hammouda F, El Heni J, Baati T, Saïd K, Kerkeni A. 2010. Reversal of cadmium-induced oxidative stress in rat erythrocytes by selenium, zinc or their combination. Exp Toxicol Pathol 62:281-288.
58. Mettang T, Alscher DM, Pauli-Magnus C, Dunst R, Kuhlmann U, Rettenmeier AW. 1999. Phthalic acid is the main metabolite of the plasticizer di(2-ethylhexyl) phthalate in peritoneal dialysis patients. Adv Perit Dial 15:229-233.
59. Milly K, Wit L, Diskin C, Tulley R. 1992. Selenium in renal failure patients. Nephron 61:139-144.
60. Miura Y, Naito M, Ablake M, Terayama H, Yi SQ, Qu N, Cheng LX, Suna S, Jitsunari F, Itoh M. 2007. Short-term effects of di-(2-ethylhexyl) phthalate on testes, liver, kidneys and pancreas in mice. Asian J Androl 9:199-205. (Pubitemid 46416580)
61. National Toxicology Program (NTP), US Department of Health and Human Sciences, Center for the Evaluation of Risks to Human Reproduction. November 2006. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Di(2-EthylHexyl)Phthalate (DEHP). Available at: http://ntp.niehs.nih. gov/ntp/ohat/phthalates/dehp/DEHP-Monograph. pdf. Accessed: 18, October, 2011.October, 2011.
62. Nève J. 1991. Physiological and nutritional importance of selenium. Experientia 47:187-193.
63. Peters JM, Taubeneck MW, Keen CL, Gonzalez FJ. 1997. Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha. Teratology 56:311-316. (Pubitemid 28035177)
64. Rothenbacher KP, Kimmel R, Hildenbrand S, Schmahl FW, Dartsch PC. 1998. Nephrotoxic effects of di-(2-ethylhexyl)-phthalate (DEHP) hydrolysis products on cultured kidney epithelial cells. Hum Exp Toxicol 17:336-342. (Pubitemid 28342343)
65. Rusyn I, Peters JM, Cunningham ML. 2006. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit Rev Toxicol 36:459-479. (Pubitemid 43904319)
66. Sathyanarayana S. 2008. Phthalates and children's health. Curr Probl Pediatr Adolesc Health Care 38:34-49.
67. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J; Alberta Kidney Disease Network. 2009. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med 7:25.
68. Tsukamoto Y, Iwanami S, Marumo F. 1980. Disturbances of trace element concentrations in plasma of patients with chronic renal failure. Nephron 26:174-179. (Pubitemid 10048869)
69. U.S. Food and Drug Administration. 2001. Safety Assessment of di(2-ethylhexyl) Phthalate (DEHP) Released from Medical Devices. US Food and Drug Administration, Washington DC. Available at: http://www.fda.gov /cdrh/ost/dehp-pvc.pdf. Accessed: 18 October, 2011.ccessed: 18 October, 2011.
70. Ward JM, Peters JM, Perella CM, Gonzalez FJ. 1998. Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl) phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol Pathol 26:240-246. (Pubitemid 28155330)
71. Weitzel F, Ursini F, Wendel A. 1990. Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion. Biochim Biophys Acta 1036:88-94. (Pubitemid 20355167)
72. Witko-Sarsat V, Nguyen Khoa T, Jungers P, Drüeke T, Descamps-Latscha B. 1998. Advanced oxidation protein products: oxidative stress markers and mediators of inflammation in uremia. Adv Nephrol Necker Hosp 28:321-341.
73. Zachara BA, Adamowicz A, Trafikowska U, Pilecki A, Manitius J. 2000. Decreased plasma glutathione peroxidase activity in uraemic patients. Nephron 84:278-281. (Pubitemid 30137908)
74. Zachara BA, Adamowicz A, Trafikowska U, Trafikowska A, Manitius J, Nartowicz E. 2001. Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin. J Trace Elem Med Biol 15:201-208. (Pubitemid 34118135)
75. Zachara BA, Salak A, Koterska D, Manitius J, Wasowicz W. 2004. Selenium and glutathione peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 17:291-299. (Pubitemid 38520269)
76. Zima T, Mestek O, Nemecek K, Bártová V, Fialová J, Tesar V, Suchánek M. 1998. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 16:253-260. (Pubitemid 29056154)